Publication|Articles|November 14, 2025

Supplements and Featured Publications

  • Economic Impact of Intravenous Versus Subcutaneous Administration of Infliximab on Health System Finances and Operations

Economic Impact of Intravenous Versus Subcutaneous Administration of Infliximab on Health System Finances and Operations

This clinical brief is supported by Celltrion Inc.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo